Principal-agent theory-based cost and reimbursement structures of isavuconazole treatment in German hospitals mydrg.de

library_books

Principal-agent theory-based cost and reimbursement structures of isavuconazole treatment in German hospitals

• B.S.
• Samstag, 10.10.2020

Principal-agent theory-based cost and reimbursement structures of isavuconazole treatment in German hospitals (Wiley).

Antimykotika - Arzneimittel - Aspergillose - Begleitforschung - DRG - Isavuconazol - Krankenhausabrechnung - Reimbursement - Zusatzentgelt - URL

« Charité verschiebt wegen Corona erneut Eingriffe | Principal-agent theory-based cost and reimbursement structures of isavuconazole treatment in German hospitals | Viel Zustimmung für neue Krankenhausplanung in NRW »